With 3D screen-printing technology we are in an exciting overall market for 3D products, which will rapidly gain in size and interest over the coming years.
Industrial production using 3D processes will become more important for many companies in all kinds of industries in future, in order to determine individual consumer needs even faster and provide the appropriate solutions. In particular, series production using 3D processes will become more important, as they will result in new market opportunities for manufacturing companies.
Laxxon Medical Ltd owns the worldwide licensing rights to the 3D screen-printing process as described (see Technology) for the entire pharmaceutical industry and it grants sub-licenses to appropriate companies it collaborates with to manufacture products using the 3D screen-printing process.
Are you looking for innovative solutions or alternatives for your existing or new products and their production processes? We would be happy to have a non-binding discussion with you and look forward to hearing from you.